Topics

Mutations in the epidermal growth factor receptors (#EGFR) of cells can lead to tumour growth and the development of non-small cell lung cancer (#NSCLC). Detection of these mutations can inform treatment decisions. #LCSMpic.twitter.com/2L7OJOCNgT

12:09 EDT 13 Sep 2019 | AztraZeneca

Mutations in the epidermal growth factor receptors ( ) of cells can lead to tumour growth and the development of non-small cell lung cancer ( ). Detection of these mutations can inform treatment decisions.

Original Article: Mutations in the epidermal growth factor receptors (#EGFR) of cells can lead to tumour growth and the development of non-small cell lung cancer (#NSCLC). Detection of these mutations can inform treatment decisions. #LCSMpic.twitter.com/2L7OJOCNgT

NEXT ARTICLE

More From BioPortfolio on "Mutations in the epidermal growth factor receptors (#EGFR) of cells can lead to tumour growth and the development of non-small cell lung cancer (#NSCLC). Detection of these mutations can inform treatment decisions. #LCSMpic.twitter.com/2L7OJOCNgT"

Quick Search

Relevant Topic

Gilotrif (afatinib)
GILOTRIF (afatinib) is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L8...